Apollo Health Ventures leverages venture building and early-stage investing to create and accelerate transformational companies focused on age-related healthcare, particularly neurodegenerative diseases and immune-mediated inflammatory conditions. They combine scientific expertise, operational support, and capital access to minimize risk and maximize value creation across Europe and the US.
Bevorzugte Reifephase für die erste Finanzierung.
Age-related healthcare, neurodegenerative diseases, immune-mediated inflammatory diseases, at-home therapy solutions, AI-powered drug discovery, antibody therapies, hematologic malignancies
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...